In humans, circulating levels of osteocalcin are negatively correlated with markers of the metabolic syndrome and diabetes, while limited evidence supports the association between genetic variants in osteocalcin and its receptors and dysregulated glucose metabolism (8, 9). The gene discussed is BGLAP; the disease is metabolic syndrome.